INTRODUCTION General Introduction

Malaria
Malaria is one of the most important and widespread diseases of humans. In 2010 around 216 million cases were reported, including 655,000 deaths. 1 The disease is caused by transmission of one of five species of Plasmodium protozoan by Anopheles mosquitoes. The species of Plasmodium that is prevalent depends on the region, with Plasmodium falciparum being the most common, as well as the most dangerous.
Transmission rates of malaria depend primarily upon the particular species of
Anopheles that is present locally; with biting frequency, density, and whether or not mosquitoes are present seasonally or all year being important factors. 2 Because of this, only around 25 of the over 400 species of Anopheles make for good vectors. 3 There have been many efforts at malaria prevention which have had various degrees of effectiveness in different regions. One of the primary methods of prevention used is vector control, or control of the Anopheles mosquitoes which transmit malaria. This can be accomplished in a variety of ways; one of the most common is by deploying mosquito nets to be used while sleeping. These can be treated with insecticides, which has been shown to greatly reduce mortality in children in areas where deployed. 4 Efficacy of bed nets, especially insecticide treated nets, is generally very high, however in some areas the main species of Anopheles isn't active during sleeping hours when the nets are used; this causes them to have minimal effects in these areas. Use of insecticides indoors is another important area for vector control, though again efficacy can depend on the local Anopheles species behavior and whether resistance has developed. 2 Currently, artemisinin combination treatment is the preferred method of treatment for typical Plasmodium malaria infections. However, in recent years, resistance to these treatments has arisen in western Cambodia and along the Thailand-Myanmar border. 5 This is the same region that in the past has first shown resistance to previously used antimalarials before spreading to other regions, therefore the need for new antimalarial drugs is high.
Plasmodium falciparum
Plasmodium falciparum is the primary causative agent of malaria in sub-Saharan
Africa and much of Asia, and accounts for around 90% of all cases of malaria worldwide each year. 1 P. falciparum has a complex, multi-stage life-cycle which is intrinsically tied to the symptoms of malaria ( Figure 1 ). 2, 6 Infections begin when an infected female Anopheles mosquito bites a human, transmitting sporozoites into the host body which then travel to the liver. In the liver sporozoites reproduce inside liver cells for around one week before eventually bursting, releasing merozoites into the bloodstream which proceed to infect red blood cells. The characteristic fever peaks of malaria are caused by cycles of asexual reproduction in human red blood cells which cause the cells to burst, releasing new merozoites into the system. Some merozoites eventually develop into gametocytes which then are transmitted into a mosquito vector where sexual reproduction occurs.
The Apicoplast
Plasmodium falciparum is a member of the phylum Apicomplexa which is primarily characterized by the presence of a non-photosynthetic, chloroplast-like organelle called the apicoplast. The apicoplast has been shown to be essential for survival of Plasmodium, though loss of the apicoplast isn't immediately fatal, however, it results in a "delayed death" where the parasite can survive until the cell divides; after division the progeny are unviable. 7, 8 Because of the importance of the apicoplast for survival of the organism, much work has been done to elucidate its essential functions as well as attempts at finding potential drug Figure 1 . The human phase of the falciparum life cycle begins when sporozoites enter the blood stream after a bite from a female Anopheles mosquito. Sporozoites make their way to the liver where they enter a hepatocyte and begin to multiply. After around one week the hepatocytes burst and merozoites enter the blood stream to infect blood cells. In this stage merozoites reproduce asexually, with some individuals eventually developing into sexual forms (gametocytes). The parasites are stuck in this phase until they are taken up by a feeding mosquito where they are able to reproduce sexually, eventually forming a new generation of sporozoites which are again able to infect a human host. targets. 9 One of the reasons apicoplast functions are attractive for drug targets because is because of the uniqueness of the apicoplast.
The apicoplast is a four-membraned organelle which is thought to have arisen through a secondary symbiotic event where a photosynthetic algae was endosymbiosed by a different eukaryotic phagotroph. 6 Subsequently, the apicoplast has lost its photosynthetic ability (with one recently discovered exception, Chromera velia). 6 In addition, much of the genetic material of the organism that became the apicoplast has been transferred to nucleus, leaving behind a 35kb circular genome. Because of this, much of the machinery needed for upkeep of the apicoplast must be transported into the apicoplast. Bioinformatics analyses of the Plasmodium falciparum genome has shown an estimated 466 proteins that are targeted to the apicoplast from the nuclear genome. 
Pfprex and apPOL
One of the genes targeted to the apicoplast is PfPREX (Plasmodium falciparum Plastidic DNA Replication/Repair Enzyme Complex), which encodes for a polyprotein that contains the DNA primase, helicase, and replicative polymerase involved in replication of the apicoplast genome ( Figure 3) . 11 This gene is notable for being the first known example of a single gene encoding for each of a DNA primase, helicase, and polymerase. 11 Interestingly, while the primase and helicase have been shown to be distantly related to T7 bacteriophage primases and helicases, the DNA polymerase of PfPREX is most closely related to the DNA polymerase I (an A-type polymerase) of Aquifex aeolicus, a thermophilic bacteria.
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Interference with these proteins, as well as others involved in replication of the apicoplast's genome, are thought to be the source of the "delayed death" effect observed after treatment with certain antibiotics. 12 For example, the apicoplast-targeted protein Topoisomerase II has been shown to be inhibited by ciprofloxacin, a type of fluoroquinolone. 13 The DNA polymerase (apPOL) is especially interesting as a drug target because it is highly divergent from human polymerases and even other A-family polymerases; the highest level of sequence homology with human polymerases is less than 25%. 14 Because of the interest in knowing more about the workings of the replication machinery of the apicoplast genome, our lab has started investigating the properties of the proteins expressed by PfPREX.
Thesis Outline
For my M.S. thesis project I examined the biochemical properties of apPOL, the apicoplasttargeted DNA-polymerase encoded in the PfPREX gene of Plasmodium falciparum. Chapter two contains a study published in the journal Biochemistry, which examines the fidelity, mismatch extension, and proofreading abilities of apPOL. Chapter three has a general conclusion which will discuss the findings of this research project as well as future directions for the project. The human parasite Plasmodia falciparum is a member of the phylum Apicomplexa and the most common causative agent of malaria 4 . Apicomplexa also contains the causative agents of several other economically important animal diseases such as Toxoplasmosis (human and feline), Babesiosis (cattle and human) and Coccidiosis (poultry) 5 . Nearly all members of Apicomplexa contain an unusual organelle called the apicoplast. The apicoplast is evolutionarily related to the chloroplast and is thought to have arisen through a symbiotic event with red algae 4 . The function of the apicoplast has been enigmatic until recently. The apicoplast participates in several metabolic pathways, including the biosynthesis of fatty acids, heme, iron-sulfur clusters, and isoprenoids 6 . The parasite is completely dependent on the apicoplast for the synthesis of isoprenoids and defects in apicoplast metabolism, or its failure to replicate and divide lead to death of the organism 7 . Due to the essential nature of the apicoplast and its uniqueness among eukaryotes, the apicoplast has been identified as a highly promising drug target 8 . It has been estimated that approximately 550 proteins reside within the apicoplast with a significant number of those being dedicated to translation (8%), transcription (1%), and DNA replication (3%) 9 . The proteins that carry-out these fundamental processes are absolutely required for apicoplast function and are therefore promising drug targets. Indeed, several antibiotics with confirmed anti-malarial activity target the following apicoplast enzymes: the 70S ribosome (clindamycin, tetracycline);
isoleucine tRNA synthetase (mupirocin); and DNA gyrase (ciprofloxacin) 10 .
The P. falciparum apicoplast genome is replicated by an A-family DNA polymerase (apPOL) that is clearly of prokaryotic origin. A recent bioinformatic analysis has shown that there are four lineages that are related to, but separate from, the prototypical A-family DNA polymerases 11 . These four lineages are made up of DNA polymerases belonging to thermophilic viruses, Aquificaceae/Hydrogenothermaceae, Apicomplexa (which includes Plasmodia), and various unrelated bacteria 11 . While many A-family DNA polymerases from the "typical" lineage have been extensively characterized at the biochemical and structural level (e.g., E. coli Pol I, Taq polymerase, T7 phage DNA polymerase, mitochondrial DNA polymerase γ), a thorough characterization of polymerases from the other four distinct Afamily lineages is lacking. In addition to being a member of one of the atypical A-family lineages, apPOL is an attractive drug target due to its role in apicoplast genome replication.
Although humans contain three A-family polymerases (pol θ, pol ν, and pol γ), the homology between apPOL and these polymerases is very low (< 24%). On the other hand, the homology between the apPOLs from the two primary causative agents of human malaria is quite high (84% identity between P. falciparum and P. vivax), suggesting that drugs targeted against the P. falciparum apPOL would be effective in treating malaria caused by P. vivax as well. The P. falciparum apicoplast DNA polymerase is expressed as part of a polyprotein made up of a DNA primase, helicase, and the polymerase 12 . Following import into the apicoplast a protease(s) of unknown identity separates the three proteins 13 .
Replication-induced mutations are governed by a combination of the fidelity of the DNA polymerase (i.e., the probability of inserting an incorrect nucleotide opposite the templating base), its ability to extend the mismatch, and its counteracting exonuclease activity (i.e., proofreading) 14, 15 . The relative contribution of each of these processes is often overlooked and DNA polymerase fidelity is the focus of most studies [16] [17] [18] . The fidelity of a fragment of P. falciparum apicoplast DNA polymerase has been recently reported 18 . To obtain a more complete picture of the mutagenic profile of apPOL, we have extended these studies to include mismatch-extension and proof-reading activity. Based on bioinformatic analysis, a different polymerase fragment was constructed to contain an additional 38 amino acids at the N-terminus and our steady-state kinetic analysis indicates that it is significantly more active than the previous version, with a fidelity more reminiscent of a replicative DNA polymerase 18 . It was found that the efficiency of mismatch extension is more important to the overall mutation frequency than the intrinsic fidelity of the polymerase. While the proofreading activity of each mismatch is relatively similar, the ability of the polymerase to extend a particular mismatch varies by over 350-fold. A linker region between the primase and helicase is proteolytically cleaved and it is assumed that the protein is cleaved between the helicase and polymerase as well 13 . Based on protein sequence alignments of POM1 from the Plasmodia genus, a likely boundary for the polymerase protein spanning amino residues 1389 through 2016 was identified. This protein sequence was then converted to DNA sequence using optimal E. coli codons and synthesized (Genescript). The synthesized gene was sub-cloned from the puc18 vector into the pet28b expression vector using the NdeI and BamHI restriction sites. The Quickchange method of mutagenesis was employed to produce the exonuclease negative mutant (apPOL exo-). The sequence of the forward primer used for mutagenesis is as follows: 5'-gatattaaatattgcggcctgaatatccaaaccacgggtctggaagtg-3' with the codons for the D1470N and E1472Q mutations are shown in bold. The reverse primer was the reverse complement of the forward.
Material and Methods
Materials-
Protein Expression, and Purification-The purification protocol for the wild-type (apPOL) and exonuclease deficient (apPOL exo-) polymerases were identical. Either the pet28-apPOL or pet28-apPOL exo-vectors were transformed into BL21(DE3) E. coli cells and a single colony was used to inoculate 100-ml flasks of LB-kanamycin that were shaken for 16 h at 37 °C. A 10 ml of starter culture was used to inoculate two 1-liter flasks of LB-kanamycin per protein, which were shaken at 225 rpm at 37 °C to an A600 of 0.8. The flasks were then cooled to 18 °C, and expression was induced by the addition of 0.2 mM (final) isopropyl 1-thio-β-d-galactopyranoside. After 16 h the cells were collected by centrifugation at 4000 × g for 20 minutes, and pellets were frozen at −20 °C.
Target protein purification relied on a hexahistidine tag provided by the pet28 vector.
Cell pellets containing expressed apPOL or apPOL exo-(2 liters) were resuspended in 100 ml of Loading Buffer (20 mM Tris-HCl, 500 mM NaCl, 5 mM imidazole, 20% glycerol at pH buffer. Gels were run for 3 -3.5 h at a constant power of 60 W, visualized using a Typhoon Phosphorimager, and analyzed using the ImageJ software (NIH). The initial rate velocities were averaged (each assay was performed 2-5 times) and fitted to the Michaelis-Menton equation. The errors given for each parameter (kcat and Km) are standard errors to the fit.
Steady state Mismatch Extension Kinetics-
The 48 different substrates that were used to investigate the mismatch extension kinetics of apPOL exo-were as follows: P2 with T1-T4 and   T9-T16; P3 with T5-T16; P4 with T1-T12; and P5 with T1-T8 and T13-T16 (Supplemental   Table S1 ). The reactions were performed in the standard assay buffer at 25 o C and contained 2 µM DNA, 80 nM apPOL exo-, and 2 mM dNTP, and were quenched at times points ranging from 1.25 to 60 minutes, depending on the reaction. Analysis of the gel products was the same as above and the rates are averages of three independent reactions.
Steady-state exonuclease Kinetics -The exonuclease experiments were performed using 8 nM apPOL, 2 µM DNA and were quenched at time points of 1 and 5 minutes. Substrates used for these experiments were P2-P5 annealed to each of T2, T6, T10, and T14. Analysis of the gel products was the same as for the mismatch extension kinetics and the rates are averages of two independent reactions.
Results and Discussion
P. falciparum apPOL exo-Misincorporation Kinetics-The mutagenesis frequency of a DNA polymerase depends on several factors. The first is the intrinsic fidelity of the polymerase active site (i.e., the probability of incorrect nucleotide incorporation), which is a commonly examined property of DNA polymerases and several different methods have been used to determine it, including pre-steady state kinetics, steady-state kinetics, and direct competition assays 19 . Apparently, all three methods yield similar results, although there are theoretical concerns with using single-nucleotide incorporation steady-state kinetics when the dissociation rate of the polymerase from the DNA product is very rate-limiting 20 . Slow product dissociation may occur when a highly processive polymerase is stalled at a correctly matched n+1 DNA product and cannot continue polymerizing due to omission of the next correct nucleotide 21 . To decrease the effect this potential concern, the DNA templates were designed to contain a five nucleotide homopolymeric extension and a low concentration (20 µM) of the correct nucleotide for incorporation across the repeat is included in the reactions.
Control reactions indicate that at this low concentration the nucleotide does not incorporate across from the position of interest, yet the nucleotide tail is very rapidly filled in. A substrate of this type allows a processive polymerase to quickly "run-off" the DNA substrate via five rounds of very rapid nucleotide incorporations.
The steady-state kinetic parameters of the exonuclease deficient apPOL exo-for the four correct nucleotide incorporations and nine out of the twelve possible mismatches are given in Table I . The values determined here for apPOL exo-do not correspond well to a previous investigation using a shorter version of the P. falciparum apicoplast DNA polymerase 18 . The most striking difference between the two reports is that our kcat values S1 ). The absence of these residues may be responsible for the much reduced activity. It is also substrate conversion under polymerase excess conditions) is consistent with either a polymerase defect or the polymerase has a Kd-DNA that is significantly above 10 nM.
In addition to significantly greater kcat values for correct nucleotide incorporation, a much wider variation in kcat values between correct and incorrect incorporations was observed (Table I ). In the previous study, the kcat values ranged from a 13.7-fold decrease to a 1.5-fold increase for incorrect versus correct incorporation 18 . The decrease in kcat values reported here for incorrect incorporation range from 412-to 54-fold. This magnitude of decrease is within a similar range as most other well-characterized high-fidelity DNA polymerases 19, 23 . Again, the differences between the previously published data and those reported here may be the result of using different polymerase constructs or different methods of kinetic analysis.
There is also a lack of correspondence between the Km-dNTP data reported here and the values reported by Kennedy et al., although not as great as with the kcat values. 18 As expected, we find that the purine nucleotides to have a smaller Km than the pyrimidine nucleotides (1.7 and 0.7 µM for dATP and dGTP, respectively, versus 5.1 and 7.3 µM for dTTP and dCTP, respectively). There are no clear trends in the misincorporation data, other than pyrimidine-pyrimidine misincorporations tend to be strongly disfavored.
The fidelity of a polymerase can be determined by the ratio of (kcat/Km)incorrect/(kcat/Km)correct 24, 25 . Based on this formula, the fidelity of apPOL exo-ranges previous measurements, which is likely a reflection of the larger differences in kcat between correct and incorrect incorporations that is observed here. However, the correspondence between our relative ranking of misincorporations based on fidelity measurements and those previously is, for the most part, quite good (Table I and misincorporations. The source of these discrepancies is unclear, but it appears that our polymerase construct behaves more similar to Klenow polymerase, where dATP:dAMP is also the 2 nd most likely mutation and dCTP:dTMP is the 11 th most likely using steady-state kinetic methods.
DNA Mismatch Removal and Extension-
A qualitative examination of the misincorporation gels indicated that some mismatches were easily extended to the end of the DNA substrate, whereas other mismatches appeared to extend only to the n+1 and n+2 positions. This observation prompted an investigation of the second factor that governs mutation frequency, which is the ratio between the rate of mismatch removal (i.e., proofreading) and the ability of the polymerase to extend the mismatch 15 . The mismatch removal rate is relatively constant for all 12 possible DNA mismatches (less than 3-fold variation, Table II ) but is 2-to 14-fold faster than removal of the four correctly-matched base pairs. In contrast to mismatch removal, the rate of mismatch extension varies much more widely (greater than 350-fold), depending on both the nature of the mismatch and the templating base that follows the mismatch ( Fig. 1, 2, and 3 ). Because it was initially observed that the downstream templating base strongly affected mismatch extension frequency (Fig. 2) , the 12 base pair mismatches with all four possible templating bases were examined (i.e., 48 total DNA substrates). Due to the large number of DNA substrates, a determination of Km and kcat for each substrate was beyond the scope of this investigation and therefore only the apparent-kcat for each mismatch extension reaction was determined using nucleotide concentration that was assumed to be saturating or near-saturating (2.0 mM dNTP).
There are several general trends that are observed in the mismatch extension data (Figures 1 and 3) . The most efficiently extended mismatches tend to be purine-pyrimidine or pyrimidine-purine (G:T, C:A, A:C, and C:T) and the least efficiently extended mismatches are purine-purine and pyrimidine-pyrimidine (A:A, T:T, A:G, and T:C). Although useful, the average apparent-kcat values for mismatch extension given in Fig. 1 obscures the significant dependency of mismatch extension efficiency on the templating base that follows the mismatch. For example, the C:A mismatch is extended with a relatively high rate when T or C is the templating base (C:AT and C:AC), but is much less efficient when A is the templating base (C:AA). In the case of the A:C mismatch, only the DNA substrate with a templating T supports a high rate of mismatch extension (A:CT). This pattern could possibly be the result of primer slippage (i.e., the mismatched template nucleotide looping out and allowing the primer to anneal to the downstream base); however, a close analysis of the gel indicated that the product of this reaction was of the expected length, indicating that a primer slippage did not occur.
An analysis of the data shown in Fig. 3 allows some general conclusions to be drawn from the templating nucleotide data. Mismatches are most efficiently extended when the templating base is a pyrimidine rather than a purine, with average apparent kcat values of 0.02 and 0.005 sec -1 , respectively. The strong sequence dependence that is observed in the mismatch extension reactions suggests that the incoming nucleotide plays a significant role in compensating for alterations in the structure of the polymerase active site due to upstream mismatched DNA. As purines provide more binding energy than pyrimidines, it is not unexpected that these nucleotides are able to provide a greater compensatory effect.
Based on our misincorporation, exonuclease, and mismatch extension data, we have ranked possible mutations from the most to least likely to occur (Fig. 4) . These values were obtained by multiplying the fidelity by the ratio of mismatch extension to mismatch removal rate [ranking = fidelity*(extension/removal)]. While these values do not represent a kinetic constant and have no true physical meaning, they are useful for comparisons. The intent of this calculation is to take into account all three selection steps that govern mutagenesis frequency. The higher the value, the more likely it is that a particular mutation will occur.
Based on these values, the four most likely mutations are the transition mutations GA when a T is the downstream base and TC when T, C, or G is the downstream base. There are only a few transversions ranking in the upper third of the most likely mutations (Fig. 4A) .
Those are AC when C is the downstream base, AT when G or T is the downstream base, and G T when A is the downstream base.
There is a lack of correspondence between the relative rankings for mismatch extension and misincorporation probability ( Fig. 1 and Table I ). For example, A:A and G:A are ranked 2 nd and 5 th for misincorporation probability but 10 th and 9 th for mismatch extension, respectively (using the averaged data from Fig. 1 ). On the other hand, the C:A and A:C mismatches are 7 th and 8 th for misincorporation probability but 2 rd and 3 th for mismatch extension, respectively. The opposing rankings for these mutations lessen the effects of either low fidelity or high mismatch extension rate, reducing the probability that they will occur. The most notable exception to this pattern is G:T, which is ranked near the top in both misincorporation probability and mismatch extension.
Of course, the rank-order of the mutations shown in Fig. 4 may not entirely reflect the order of polymerase-induced mutation probability in the apicoplast of P. falciparum. Very little is known regarding mismatch repair within the apicoplast. Inspection of the P.
falciparum genome revealed several genes encoding putative DNA repair proteins that appear to contain apicoplast targeting signals 26 . One of these proteins contains a MutS domain and the typical ABC motifs of MutS homologs, therefore some form of mismatch repair may occur within the apicoplast. Human MutS appears to show no strong preference for any particular mismatch (less than 2-fold differences) 27 , whereas prokaryotic MutS displays large differences in efficiencies 28 . Notably, the mismatch least efficiently repaired (pyrimidine-pyrimidine) is also the least likely to occur.
The fidelity and mutagenic potential are of considerable importance to the biology of the Plasmodia because its apicoplast apparently contains only a single DNA polymerase.
High fidelity is necessary for preserving genetic information and avoiding harmful mutations that may lead to organismal dysfunction, whereas mutagenesis is necessary for generating genetic diversity and the long-term evolution of a species. The fidelity measurements reported here clearly place apPOL in the group of high-fidelity DNA polymerases with error rates ranging from 10 -4 to less than 10 -6 . Unlike the mitochondria and apicoplast, which contain only a single DNA polymerase, most organisms harbor several low-fidelity polymerases that are responsible for replicating past DNA lesions (i.e., translesion synthesis polymerases). The high fidelity of apPOL suggests that DNA lesions are not easily bypassed and it is likely that the apPOL stalls at most or all types of DNA lesions. This suggests the existence of DNA repair pathways like those found in the mitochondria (e.g, base excision repair) 29 . As mentioned above, there are several proteins containing predicted apicoplast targeting signal sequences that are annotated as DNA repair proteins and it appears a base excision repair system may be present 26 . The replication and repair of the P. falciparum apicoplast genome is poorly characterized and with the ever-increasing drug resistance of P.
falciparium, combined with the potential of the apicoplast as a drug target, determining the fundamental mechanisms of the apicoplast genome replication and repair is an important step toward finding new malaria treatments that target novel aspects of the parasites biology. 
Summary
Over the course of our investigation of apPOL it has been our goal to describe its fidelity and kinetics under various conditions. We first examined the fidelity of apPOL and found that its fidelity is comparable to those of high-fidelity A family polymerases. 1 We also
showed that the likelihood of individual misincorporations can vary greatly depending on the template and incoming nucleotides and that the largest factor in this is the ability of apPOL to extend past the mismatch as opposed to its ability to incorporate the nucleotide or a difference in exonuclease activity for each mismatch. We found that fidelity values for each mismatch pair varies by around 50-fold but extension kinetic values can vary up to 350-fold for values we were able to observe. Once values for fidelity, apparent kcat of extension of mismatch, and apparent kcat of the 3' to 5' exonuclease removing the mismatch were obtained, we generated a constant for each mismatch that would represent its relative likelihood of happening for each downstream base. This value was generated using the following formula.
ℎ = * ( )
This formula gave us a unit less value that doesn't represent any actual kinetic property but is useful for being able to compare relative likelihoods of each mutation. We found that the most likely misincorporations to occur were T being inserted across from G with T as the downstream base and G being inserted across from T with either T, C, or G as the downstream base.
Future Directions I am currently characterizing the ability of apPOL to replicate across a non-coding abasic lesion. I've found that while the kpol (pre-steady state rate constant) of apPOL inserting dATP across from the abasic site was slightly higher than that of inserting dGTP, the KD for dGTP is 2-fold lower than KD for dATP, making the likelihood of insertion of dGTP as measured by efficiency (kpol/KD) nearly 2-fold greater than dATP. This is significantly different than all other characterized polymerases, which strongly prefer dATP over all other nucleotides (the so-called "A-rule"). However, data from preliminary extension assays show that the extension of A across from the abasic site is much efficient than G, indicating that in the case of apPOL the "A-rule" is enforced at the extension step rather than insertion. Next, we examined the 3' to 5' exonuclease activity of apPOL and found that its apparent kcat value was around ~10-fold higher than the kpol of either dATP or dGTP insertion. It was also comparable to the apparent kcat of the exonuclease removing a mismatched base. The next step of our investigation of apPOL is to analyze the polymerase's ability to extend past improperly inserted bases across from an abasic site. To do this we plan on using a recently described high-throughput method to look at the fidelity of apPOL around the abasic site. 2 The method involves running the extension reaction as we have before but with new DNA templates. The four templates differ at the downstream base adjacent to the abasic site as well as around 10 bases upstream, the upstream differences are barcodes there to be able to identify each template after sequencing. After running the assay, the products are gel purified to isolate the primer strand which is then amplified with a PCR reaction to
